POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab.
Wei CH, Wang EW, Ma L, Zhou Y, Zheng L, Hampel H, Shehayeb S, Lee S, Cohen J, Kohut A, Fan F, Rosen S, Wu X, Shen B, Zhao Y.
Wei CH, et al. Among authors: zheng l.
Cancers (Basel). 2023 Nov 30;15(23):5674. doi: 10.3390/cancers15235674.
Cancers (Basel). 2023.
PMID: 38067377
Free PMC article.